Upgrade to SI Premium - Free Trial

Qiagen NV (QGEN) PT Raised to $47 at Baird

July 13, 2026 7:18 AM
Baird analyst Catherine Schulte raised the price target on Qiagen NV (NYSE: QGEN) to $47.00 (from $43.00) while maintaining a Outperform rating.

Categories

Analyst PT Change